FLEET ENEMA OTC
Generic Name and Formulations:
Monobasic sodium phosphate 19g, dibasic sodium phosphate 7g; per 118mL; latex-free; contains 4.4g sodium per enema.
Fleet, C.B., Company
Indications for FLEET ENEMA:
Occasional constipation or bowel cleansing before rectal exam.
1 enema rectally daily; may be used up to 7 days. Results usually within 1–5mins; re-evaluate if no relief after 7 days.
Use other forms.
Megacolon. Bowel obstruction. Imperforate anus. CHF.
Sodium restricted diet. Impaired renal or cardiac function. Electrolyte disturbances. Colostomy. Discontinue if rectal bleeding or if no bowel movement occurs. Frequent use leads to dependence. Pregnancy. Nursing mothers.
Electrolyte imbalances possible with calcium channel blockers, diuretics; use cautiously.
Original enema—133mL; Extra—230mL
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Predicting Seizure Risk Following Ischemic Stroke With SeLECT Score
- Surgical Outcomes Associated With Trigger Site Deactivation for Migraines
- Combined Exercise Training Increases BDNF in Relapsing-Remitting MS
- Exome-Targeted Capture Sequencing Can Diagnose Previously-Undetected Ataxia
- Strategies for Preventing and Treating Delirium
- High Total Cholesterol Neuroprotective Against Cognitive Decline